Trade-Ideas: Quintiles Transnational Holdings (Q) Is Today's New Lifetime High Stock
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.
Trade-Ideas LLC identified
Quintiles Transnational Holdings
(
) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Quintiles Transnational Holdings as such a stock due to the following factors:
- Q has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $39.6 million.
- Q has traded 1,354 shares today.
- Q is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in Q with the Ticky from Trade-Ideas. See the FREE profile for Q NOW at Trade-Ideas
More details on Q:
Quintiles Transnational Holdings Inc., through its subsidiary, Quintiles Transnational Corp., provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the Asia-Pacific. Q has a PE ratio of 24.4. Currently there are 11 analysts that rate Quintiles Transnational Holdings a buy, no analysts rate it a sell, and 4 rate it a hold.
The average volume for Quintiles Transnational Holdings has been 533,800 shares per day over the past 30 days. Quintiles Transnational has a market cap of $8.3 billion and is part of the health care sector and health services industry. Shares are up 14.2% year-to-date as of the close of trading on Friday.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Analysis:
rates Quintiles Transnational Holdings as a
. Among the areas we feel are negative, one of the most important has been poor profit margins.
Highlights from the ratings report include:
- The gross profit margin for QUINTILES TRANSNATIONAL HLDG is currently lower than what is desirable, coming in at 29.84%. Regardless of Q's low profit margin, it has managed to increase from the same period last year. Despite the mixed results of the gross profit margin, the net profit margin of 6.26% trails the industry average.
- The company, on the basis of net income growth from the same quarter one year ago, has significantly underperformed compared to the Life Sciences Tools & Services industry average, but is greater than that of the S&P 500. The net income increased by 21.1% when compared to the same quarter one year prior, going from $73.00 million to $88.43 million.
- Q's revenue growth trails the industry average of 16.9%. Since the same quarter one year prior, revenues slightly increased by 2.3%. Growth in the company's revenue appears to have helped boost the earnings per share.
- This stock has increased by 32.55% over the past year, outperforming the rise in the S&P 500 Index during the same period. Regarding the future course of this stock, we feel that the risks involved in investing in Q do not compensate for any future upside potential, despite the fact that it has seen nice gains over the past 12 months.
- QUINTILES TRANSNATIONAL HLDG has improved earnings per share by 25.4% in the most recent quarter compared to the same quarter a year ago. The company has demonstrated a pattern of positive earnings per share growth over the past year. We feel that this trend should continue. This trend suggests that the performance of the business is improving. During the past fiscal year, QUINTILES TRANSNATIONAL HLDG increased its bottom line by earning $2.72 versus $1.35 in the prior year. This year, the market expects an improvement in earnings ($3.10 versus $2.72).
- You can view the full Quintiles Transnational Holdings Ratings Report.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
null